Skip to main content

Table 3 EQ-VAS by socio-demographic and clinical characteristics

From: Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine

Variable

Total

Frequency (%) or median [Q1-Q3]

N = 275

Patients with better HRQoL

Frequency (%) or median [Q1-Q3]

n = 148

Patients with worse HRQoL

Frequency (%) or median [Q1-Q3]

n = 127

p-value a

Age (year)

  < 48

28(10.2)

23 (15.5)

5 (3.9)

0.008b

 48–57

77(28.0)

42 (28.4)

35 (27.6)

 

 58–67

114(41.5)

60 (40.5)

54 (42.5)

 

 68–77

43(15.6)

16 (10.8)

27 (21.3)

 

  ≥ 78

13(4.7)

7 (4.7)

6 (4.7)

 

Gender

 Female

121(44.0)

62 (41.9)

59 (46.5)

0.447 b

 Male

154(56.0)

86 (58.1)

68 (53.5)

 

Residency

 City

108 (39.3)

57 (38.5)

51 (40.2)

0.819 b

 Village

135(49.1)

75 (50.7)

60 (47.2)

 

 Palestinian refugee camps

32(11.6)

16 (10.8)

16 (12.6)

 

Social status

 Married

198(72.0)

113 (76.4)

85 (66.9)

 

 Single, widowed, divorced

77(28.0)

35 (23.6)

42 (33.1)

0.083 b

Educational level

 No formal

66(24.0)

27 (18.2)

39 (30.7)

 

 Primary

106(38.5)

51 (34.5)

55 (43.3)

< 0.001b

 Secondary

60(21.8)

34 (30.0)

26 (20.5)

 

 University

43(15.6)

36 (24.3)

7 (5.5)

 

Occupation

 Employed

129(46.9)

88 (59.5)

41 (32.3)

< 0.001b

 Unemployed

146(53.1)

60 (40.5)

86 (67.7)

 

Income (NIS)

 Moderate to high

116(42.2)

79 (53.4)

37 (29.1)

< 0.001b

 Low

159(57.8)

69 (46.6)

90 (70.9)

 

BMI

 Normal

49(17.8)

24 (16.2)

25 (19.7)

0.570 b

 Overweight

129(46.9)

68 (45.9)

61 (48.0)

 

 Obese

97(35.3)

56 (37.8)

41 (32.3)

 

Cigarette

 Not smoker

144(52.4)

85 (57.4)

59 (60.5)

0.257 b

 Light

7(2.5)

4 (2.7)

3 (2.4)

 

 Moderate

36(13.1)

17 (11.5)

19 (15.0)

 

 Heavy

13(4.7)

4 (2.7)

9 (7.1)

 

 Ex-smoker

75(27.3)

38 (25.7)

37 (29.1)

 

Duration of the disease (year)

  ≤ 3

139 (50.5)

86(58.1)

53(41.7)

 

 4–5

71 (25.8)

38(25.7)

33(26/0)

< 0.001b

  > 5

65 (23.6)

24(16.2)

41(32.3)

 

Total number of medications

 1–3

81(29.5)

47 (31.8)

34 (26.8)

0.055 b

 4–6

161(58.5)

78 (52.7)

83 (65.4)

 

  ≥ 7

33(12.0)

23 (15.5)

10 (7.9)

 

Total number of chronic diseases

 0

13(4.7)

11 (7.4)

2 (1.6)

 

 1

38(13.8)

22 (14.9)

16 (12.6)

0.070 b

 2

84(30.5)

37 (25.0)

47 (37.0)

 

 3

73(26.5)

41 (27.7)

32 (25.2)

 

  ≥ 4

67(24.4)

37 (25.0)

30 (23.6)

 

PEPPI-5

17[15–20]

18[16–20]

16[14–19]

0.002c

SEMCD-6

5.8[5–6.8]

6.1[5.3–6.8]

5.5[4.8–6.8]

0.005c

SCSES

34[29–38]

37[30–40]

31[27–36]

< 0.001c

  1. EQ-VAS European Quality of Life visual analogue scale, NIS New Israeli Shekel, BMI body mass index, PEPPI-5 Perceived Efficacy in Patient-Physician Interactions, SEMCD-6 Self-Efficacy for Managing Chronic Disease 6-Item Scale, SCSES Sullivan’s cardiac self-efficacy scale 13-items, Q1-Q2 Quartile 1 - Quartile 3
  2. a The bold values indicate P < 0.05
  3. b Statistical significance of differences calculated using the Pearson Chi-Square test
  4. c Statistical significance of differences calculated using the Mann–Whitney U test